Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2005
10/27/2005WO2005099762A1 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability
10/27/2005WO2005099761A1 Dietary supplement and method of processing same
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099752A2 Antigen delivery vectors and constructs
10/27/2005WO2005099751A2 Apparatus and method for transdermal delivery of influenza vaccine
10/27/2005WO2005099733A1 Vegetable antibacterial composition
10/27/2005WO2005099732A1 Process for producing granule containing plant extract
10/27/2005WO2005099728A1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use
10/27/2005WO2005099713A2 Novel antiviral pharmaceutical composition
10/27/2005WO2005099708A1 Composition comprising itraconazole for oral administration
10/27/2005WO2005099698A1 STABILIZED 4-AMINO-5-CHLORO-N-[(1R,3r,5S)-8-METHYL-8- AZABICYCLO[3.2.1]OCT-3-YL]-2-[1-METHYLBUT-2-YNYLOXY]-BENZAMIDE CONTAINING COMPOSITION
10/27/2005WO2005099685A1 Liquid external preparation containing sodium cromoglycate
10/27/2005WO2005099683A1 Antibacterial agent whose active ingredint is methyl paraoxybenzoate and composition for external application containing the same
10/27/2005WO2005099681A1 Tablet containing branched chain amino acid and process for producing the same
10/27/2005WO2005099674A1 Pharmaceutical compositions comprising an amphiphilic starch
10/27/2005WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005WO2005099670A1 Method for administering medicaments to subjects with swallowing difficulties and disorders
10/27/2005WO2005099669A1 Liquids containing suspended glass particles
10/27/2005WO2005099667A2 Drug delivery compositions
10/27/2005WO2005099361A2 MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
10/27/2005WO2005063819A3 Human binding molecule against cd1a
10/27/2005WO2005060375A3 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
10/27/2005WO2005051902A3 Modified mscl protein channel
10/27/2005WO2005027852A3 Compositions of polyacids and polyethers and methods for their use in reducing pain
10/27/2005WO2004110255A3 Antineoplastic agents targeted via glut transporters
10/27/2005WO2004101740A3 Clotting factor-fc chimeric proteins to treat hemophilia
10/27/2005WO2004075854A3 Microbicidal compositions and method of use
10/27/2005WO2004073648A3 Composition and methods for inhibiting cell survival
10/27/2005WO2004064760A3 Aptamer therapeutics useful in ocular pharmacotherapy
10/27/2005US20050240012 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
10/27/2005US20050239900 Use of low molecular weight amino alcohols in ophthalmic compositions
10/27/2005US20050239895 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/27/2005US20050239894 Topical composition
10/27/2005US20050239886 Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes
10/27/2005US20050239884 Compositions comprising hmg-coa reductase inhibitor
10/27/2005US20050239868 Indometacin preparation for external use
10/27/2005US20050239863 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
10/27/2005US20050239813 Pharmaceutical compositions comprising fk506 derivatives and their use for the treatment of allergic diseases
10/27/2005US20050239746 Pharmaceutical composition
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239727 for use in cosmetics, drugs
10/27/2005US20050239724 Skin penetration enhancing components
10/27/2005US20050239715 Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
10/27/2005US20050239712 Pharmaceutically active compound
10/27/2005US20050239705 Compositions and methods for topical diagnostic and therapeutic transport
10/27/2005US20050239692 Aqueous preparation containing oligopeptides and etherified cyclodextrin
10/27/2005US20050239688 Method for the synthesis of anthracycline-peptide conjugates
10/27/2005US20050239687 Complex comprising transfecting peptide vector and short interferring RNA, used as medicaments, in human and veterinary medicine, in human and animal gene therapy, in particular in hereditary diseases, as antiviral agents, as anticarcinogenic agents and inhibitors of gene overexpression
10/27/2005US20050239204 Multifunctional molecular complexes for gene transfer to cells
10/27/2005US20050239202 Methods and compositions for inhibiting the function of polynucleotide sequences
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239131 Interactive system for presenting and eliminating substances
10/27/2005US20050238870 Embolization
10/27/2005US20050238726 N-methyl D-aspartic acid (NMDA) receptor antagonism; neuroprotection
10/27/2005US20050238723 Method of producing hydroxyalkyl starch derivatives
10/27/2005US20050238722 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/27/2005US20050238720 Stable pharmaceutical composition comprising erythropoietin
10/27/2005US20050238719 Film coating
10/27/2005US20050238705 Lipid-based dispersions useful for drug delivery
10/27/2005US20050238703 Medical non-crosslinked pressure-sensitive adhesive composition, medical adhesive sheet employing the same, and process for producing medical non-crosslinked pressure-sensitive adhesive composition
10/27/2005US20050238695 Lozenge for delivery of dextromethorphan
10/27/2005US20050238681 Storage-stable compositions of glycerol monoalkyl ethers
10/27/2005US20050238676 Biliquid foam entrapment
10/27/2005US20050238674 Stable injectable compositions
10/27/2005US20050238673 compound's solubility in a medium can be enhanced by forming de novo fatty acid or fatty alcohol derived micelles in the presence of the compound; contacting the compound with a fatty acid under conditions in which said fatty acid does not substantially form micelles such as low pH
10/27/2005US20050238667 Botulinum toxin pharmaceutical compositions with enhanced potency with regard to a reference botulinum toxin pharmaceutical composition
10/27/2005US20050238664 Botulinum toxin pharmaceutical compositions with multiple stabilizers
10/27/2005US20050238663 Recombinant stabilizer botulinum toxin pharmaceutical compositions
10/27/2005US20050238649 Monomethylvaline compounds capable of conjugation to ligands
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238640 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
10/27/2005US20050238637 Vectors for molecule delivery to CD11b expressing cells
10/27/2005US20050238634 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
10/27/2005US20050238628 Methods for treating cancer
10/27/2005US20050238618 Low molecular weight polymers
10/27/2005US20050238617 Methods for increasing protein polyethylene glycol (PEG) conjugation
10/27/2005US20050238614 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
10/27/2005US20050238606 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin water solution of nucleic acid for delivery to hair follicles to inhibit hair growth
10/27/2005US20050238586 Preparation of further diagnostic agents
10/27/2005DE102004016683A1 Dauerhaft geschäumte Zusammensetzung Permanently foamed composition
10/27/2005CA2824093A1 Prodrug linker
10/27/2005CA2786794A1 Prodrug linker
10/27/2005CA2776927A1 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005CA2606138A1 Prostate cancer diagnosis and treatment
10/27/2005CA2602705A1 Polymeric prodrug with a self-immolative linker
10/27/2005CA2564878A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005CA2563870A1 Pharmaceutical compositions comprising old man's beard (usnea barbata) and st.john's wort (hypericum perforatum) and their use
10/27/2005CA2563689A1 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005CA2562932A1 Apparatus and method for transdermal delivery of influenza vaccine
10/27/2005CA2562890A1 Novel g-csf conjugates
10/27/2005CA2562806A1 Pharmaceutical compositions comprising an amphiphilic starch
10/27/2005CA2562784A1 Fluorocarbon antigen delivery vectors and constructs
10/27/2005CA2562606A1 Liquids containing suspended glass particles
10/27/2005CA2562550A1 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005CA2562495A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations
10/27/2005CA2562391A1 Solid pharmaceutical preparation
10/27/2005CA2562081A1 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability
10/26/2005EP1589067A1 Edible film
10/26/2005EP1589022A1 A mixture comprising fatty acid alcohols and APG-ether-carboxylate
10/26/2005EP1588727A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 1712